Clinical trial
Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Genotype 1-infected Patients in Taiwan
NCT00495131 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Genotype 1-infected Patients in Taiwan
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2006
- Completion date
- July 31, 2008
- Enrollment
- 308 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.